Global Health

Timelines

[The following areas are of interest to the review committee. These were last updated in January 2021.]

• Tafenoquine for radical cure of P. vivax malaria in ≥ 16 yrs
• G6PD diagnostic and treatment with TQ in patients with P. vivax malaria
• Use of Tafenoquine with Chloroquine
• Tafenoquine effectiveness in patients with P.vivax malaria
• PK/PD study in patients with P.vivax malaria
• Comparative study of TQ vs PQ
• Health outcomes and economic research/ Health economic study

GSK are more likely to support studies aligned to our current areas of interest when they are innovative and contribute to scientific knowledge relating to a product, a medical condition or advancing a technology. GSK Global Health encourages submissions throughout the year.